Sunny Reddy
Investitore di Private Equity presso Aisling Capital LLC
Profilo
Sunny joined Aisling in 2019 and serves as a Principal.
Prior to Aisling, Sunny was an Associate and Analyst at SVB Leerink, a healthcare-specialist investment bank, focusing on biopharma/therapeutics.
Prior to SVB Leerink, Sunny was a Quantitative Analyst at Bank of America Merrill Lynch specializing in credit derivative products.
He was also a research associate working in oncology drug development prior to his careers in finance and investing.
Sunny currently serves as a board observer for Forge Biologics, Garuda Therapeutics and Wugen.
His prior board service includes Monte Rosa Therapeutics (observer).
Sunny received his B.S.
in Biomedical Engineering from the Georgia Institute of Technology with high honors and was a HOPE and Zell Miller Scholar recipient.
Posizioni attive di Sunny Reddy
Società | Posizione | Inizio |
---|---|---|
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investitore di Private Equity | 01/09/2019 |
Formazione di Sunny Reddy
Georgia Institute of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Finance |
- Borsa valori
- Insiders
- Sunny Reddy